ARTUR ISAKOV: Open Payments
NPI 1841875044 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 47 payments from 10 companies in 2025. Trend: 2023 $1,031 · 2024 $1,084 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $304 |
| Paratek Pharmaceuticals, Inc. | 13 | $144 |
| Amgen Inc. | 4 | $73 |
| GENZYME CORPORATION | 1 | $62 |
| ABBVIE INC. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $32 |
| ConvaTec Inc. | 1 | $22 |
| Incyte Corporation | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| Organon LLC | 1 | $15 |
Products named: NUZYRA, COSENTYX, OTEZLA, DUPIXENT, SKYRIZI, INNOVAMATRIX AC, OPZELURA, Bimzelx.
Industry payments across NY — which companies pay providers there.
